Direct-to-consumer prescription drug advertising: Trends, impact, and implications

Research output: Contribution to journalArticle

293 Citations (Scopus)

Abstract

We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.

Original languageEnglish (US)
Pages (from-to)110-128
Number of pages19
JournalHealth Affairs
Volume19
Issue number2
StatePublished - 2000

Fingerprint

Prescription Drugs
medication
drug
trend
Drug Industry
United States Food and Drug Administration
pharmaceutical industry
Industry
Public Health
Delivery of Health Care
Drug Therapy
promotion
public health
profession
health care
Direct-to-Consumer Advertising
industry
community

ASJC Scopus subject areas

  • Health Policy
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Direct-to-consumer prescription drug advertising : Trends, impact, and implications. / Wilkes, Michael S.; Bell, Robert A.; Kravitz, Richard L.

In: Health Affairs, Vol. 19, No. 2, 2000, p. 110-128.

Research output: Contribution to journalArticle

@article{32a7906e5b6a4b958f29224b73b2b217,
title = "Direct-to-consumer prescription drug advertising: Trends, impact, and implications",
abstract = "We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.",
author = "Wilkes, {Michael S.} and Bell, {Robert A.} and Kravitz, {Richard L.}",
year = "2000",
language = "English (US)",
volume = "19",
pages = "110--128",
journal = "Health Affairs",
issn = "0278-2715",
publisher = "Project Hope",
number = "2",

}

TY - JOUR

T1 - Direct-to-consumer prescription drug advertising

T2 - Trends, impact, and implications

AU - Wilkes, Michael S.

AU - Bell, Robert A.

AU - Kravitz, Richard L.

PY - 2000

Y1 - 2000

N2 - We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.

AB - We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.

UR - http://www.scopus.com/inward/record.url?scp=0005231055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0005231055&partnerID=8YFLogxK

M3 - Article

C2 - 10718026

AN - SCOPUS:0005231055

VL - 19

SP - 110

EP - 128

JO - Health Affairs

JF - Health Affairs

SN - 0278-2715

IS - 2

ER -